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Abstract Temporin A (TA) is a small, basic, highly hydro-
phobic, antimicrobial peptide amide (FLPLIGRVLSGIL-NH2)
found in the skin of the European red frog, Rana temporaria. It
has variable antibiotic activities against a broad spectrum of
microorganisms, including clinically important methicillin-sensi-
tive and -resistant Staphylococcus aureus as well as vancomycin-
resistant Enterococcus faecium strains. In this investigation the
antimicrobial activity and structural characteristics of TA
synthetic analogs were studied. For antibacterial activity against
S. aureus and enterococcal strains, the hydrophobicity of the N-
terminal amino acid of TA was found to be important as well as a
positive charge at amino acid position 7, and bulky hydrophobic
side chains at positions 5 and 12. Replacing isoleucine with
leucine at amino acid positions 5 and 12 resulted in the greatest
enhancement of antibacterial activity. In addition, there was little
difference between the activities of TA and its all-D enantiomer,
indicating that the peptide probably exerts its effect on bacteria
via non-chiral interactions with membrane lipids. ß 2000 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
Temporin A (TA) is a small, basic, highly hydrophobic,
antimicrobial peptide found in the skin of the European red
frog, Rana temporaria [1]. It is one of a group of 21 peptides,
collectively known as the temporins, that are among the
smallest antibacterial peptides to have been isolated from an-
imal sources [1^5]. They are active against both Gram-positive
and Gram-negative bacteria and most are non-toxic to human
red blood cells at the concentrations required to kill bacteria.
TA has been synthesized previously by solid phase methods
[1,6]. We showed that the puri¢ed synthetic peptide had anti-
bacterial activity against clinically important Gram-positive
bacteria, with moderately good activity against both methicil-
lin-sensitive and methicillin-resistant strains of Staphylococcus
aureus (MSSA and MRSA, respectively), but a weaker activity
against vancomycin-resistant strains of Enterococcus faecium
(VRE).
Previous work has shown that it is possible to improve the
activities, or reduce the toxicities, of naturally occurring pep-
tide antibiotics by producing synthetic analogs with modi¢ed
primary and/or secondary structures [7]. Such research usually
also leads to a better understanding of the structural features
of a peptide that are important for its antibiotic and/or toxic
properties. This work was primarily aimed to improve the
activity of TA against clinically important bacterial strains
by synthetic modi¢cations of its primary structure and, sec-
ondarily, to obtain some information about important struc-
tural features of the peptide. The types of modi¢cations in-
cluded: (1) synthesis of enantiomeric TA (i.e. TA containing
all-D amino acids) to produce an antibiotic that would resist
enzymatic proteolysis, (2) substitution of Ile with Ala or Leu
in order to retain the hydrophobic character of Ile positions
within the TA while modifying the amino acid side chain size
and chirality (the side chain of Ile contains a chiral carbon, so
that L-Ile in TA has two isomeric forms), (3) substitution of
Arg with Lys at the amino acid position 7 in TA (i.e. con-
version of TA to temporin F (TF) [1]) to examine the e¡ect of
minor modi¢cations in the side chain structure and positive
character of this position, (4) substitution of N-terminal Phe
with Lys, in both the all-L and all-D enantiomers of TA, to
examine the e¡ect of reducing the amphipathicity of the pep-
tide and increasing its basicity (from +2 to +3) and (5) to
study the structural features of TA with circular dichroism
(CD) spectroscopy and nuclear magnetic resonance (NMR).
2. Materials and methods
2.1. Peptide synthesis, puri¢cation and characterization
Analogs were designed based on the known amphipathic K-helical
structure of TA (Fig. 1) [5]. Peptides were synthesized as C-terminal
amides by solid phase methods using Fmoc protected amino acids,
puri¢ed by preparative reverse phase-high performance liquid chro-
matography (RP-HPLC), and analyzed for purity by analytical RP-
HPLC, for composition by amino acid analysis (AAA) and for mass
by electrospray ionization mass spectrometry (ESI-MS), as previously
described [6,8]. Molecular weights were calculated using the ‘Compute
pI/MwTool’ program [9] and molecular models were generated with
the Swiss PDB Viewer program [10].
2.2. Bacterial strains and media
MSSA strain K52 and MRSA strain K35, as well as the VRE
strains 18578 and 18172, which carried the vanA and vanB genes,
respectively, were clinical isolates originating from the Laboratory
of Bacteriology, Section of Clinical Microbiology, HUCH Laboratory
Diagnostics, Helsinki University Central Hospital [6]. Additionally, S.
aureus strain ATCC 25923 and Enterococcus faecalis strain ATCC
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29212 were used for testing. For the experiments, bacterial strains
were maintained on chocolate agar plates by subculturing every 3^4
weeks.
2.3. Determination of minimal inhibitory concentration (MIC) and
bacterial killing
MIC values and bacterial killing were determined as described [6].
Brie£y, bacterial suspensions corresponding to a McFarland value of
1.0 were diluted 1:1000 in 2-fold concentrated Mueller^Hinton broth
containing Ca2, and an aliquot (25 Wl) was mixed with an aliquot (25
Wl) of a 2-fold dilution of TA analogs in deionized H2O. The MIC
was de¢ned as the lowest concentration of the analog inhibiting visible
growth after incubation at 37‡C for 20 h.
Bacterial killing was determined by cultivating 10 Wl of a suitable
dilution, made from microdilution wells, on Mueller^Hinton agar
plates and by counting colony forming units after an overnight incu-
bation at 37‡C. For colony counting only plates having 20^500 bac-
terial colonies per plate were used.
2.4. CD and NMR spectroscopy
The CD measurements were carried out with a Jasco 720 spectro-
polarimeter using a 1 mm quartz cell at 25‡C. The peptide samples
(0.1 mM) were prepared in H2O^tri£uoroethanol (TFE) solutions (0^
80 vol% TFE). For each sample ¢ve spectra were recorded at the scan
rate of 20 nm/min and averaged.
NMR measurements were carried out both in H2O and D3-TFE/
H2O (3:7, v/v). Samples of freeze-dried peptides were dissolved to
obtain 1 mM solutions. The pH was adjusted to 6.0 with a few Wl
of dilute HCl (pH not corrected for the deuteron or solvent e¡ects).
The samples were prepared to 300 Wl in a Shigemi microcell. The
NMR spectra were acquired with a 600 MHz Varian Unity NMR
spectrometer. Homonuclear two-dimensional spectra, correlation
spectroscopy, relayed correlation spectroscopy, total correlation spec-
troscopy (with mixing times of 30, 55 and 180 ms) and nuclear Over-
hauser enhancement (with mixing times of 50, 100, 200 and 400 ms),
were collected at 20‡C. The data were processed with the Felix 98
software.
3. Results
3.1. Peptide synthesis, puri¢cation and characterization
The peptides were pure, as shown by analytical RP-HPLC,
and had the expected amino acid compositions and molecular
weights, as shown by AAA and ESI-MS (Table 1).
3.2. Bacteriological assays
Changing the chirality of TA, from all-L to all-D (DTA),
produced MIC values that were similar to those of native TA,
except for E. faecalis, where there was a 2-fold improvement
in activity (Table 2). MIC values for TA and DTA varied
between 2.6 WM and 5.2 WM for staphylococci, and between
10.5 WM and 20.9 WM with enterococci. Interestingly, substi-
tution of Ile in TA with Leu (L512TA) produced a peptide
that had the same or improved potency as TA against staph-
ylococci, except for the ATCC strain, and 2-fold improved
potency against all enterococcal strains. Conversion of TA
to TF (K7TA) reduced potency by 2-fold or less against
most test strains, except S. aureus K52 where there was a
slight improvement in activity, and E. faecalis which was
equally sensitive to both peptides. MIC values were 4.4^5.2
WM for staphylococci and 17.5^20.9 WM for enterococci. The
antibacterial e¡ect of TA was strongly reduced when the ami-
no-terminal Phe of TA or DTA was replaced by L- or D-Lys,
respectively. MIC values were elevated an average of 19-fold
for staphylococci and at least 10-fold for enterococci. Re-
placement of Ile with Ala yielded a peptide without any anti-
bacterial activity (Table 2).
Killing curves for each bacterial strain tested were in good
Table 1
Amino acid sequences, net charges and masses of TA and synthetic analogs at pH 7
Peptidea Amino acid sequenceb NC Mass
Calculatedc Foundd
TA FLPLIGRVLSGIL-NH2 +2 1396 1396.4
DTA (same as TA, except all-D amino acids) +2 1396 1396.4
K1TA KLPLIGRVLSGIL-NH2 +3 1377 1377.4
DK1TA (same as K1TA, except all-D amino acids) +3 1377 1377.4
K7TA FLPLIGKVLSGIL-NH2 +2 1368 1368.2
A512TA FLPLAGRVLSGAL-NH2 +2 1312 1311.8
L512TA FLPLLGRVLSGLL-NH2 +2 1396 1395.6
NC, net charge.
aTA (i.e. Ile-5,12 TA); DTA, all-D TA; K1TA, Lys-1 TA; DK1TA, all-D K1TA; K7TA, Lys-7 TA (i.e. TF [1]); A512TA, Ala-5,12 TA;
L512TA, Leu-5,12 TA.
bAll peptides are amidated at their C-termini, and, unless otherwise indicated, all amino acids are of the L con¢guration. Single and double
amino acids replacements are in bold and underlined.
cMass of amidated peptide calculated by subtracting 2 from value calculated for free carboxyl-terminal peptide.
dMass from ESI-MS [(M+2H ionU2)32].
Fig. 1. Helical wheel diagram for TA, showing the relative positions
of constituent amino acids when the peptide is in a helical confor-
mation, and the positions of amino acid replacements described in
the text. The numbers of the amino acid positions, 1 through 13, in-
crease around the circumference of the circle in a clockwise direc-
tion. For DTA, the numbers would increase in a counterclockwise
direction. The dotted line indicates that the helix surface can be di-
vided into hydrophobic and hydrophilic halves, demonstrating the
amphipathic nature of the peptide.
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agreement with MIC values and revealed that DTA was prac-
tically as e¡ective in killing staphylococci and enterococci as
the native TA (data not shown). Substitution of Arg with Lys
at position 7 did not change the killing activity of TA against
staphylococcal strains whereas the activity against VRE
strains seemed to be slightly weakened. In agreement with
MIC values, replacement of Ile at positions 5 and 12 by
Leu produced a peptide with slightly enhanced bacterial ac-
tivity against both staphylococci and enterococci. In contrast,
substitution of Ala for the same positions abolished totally the
killing activity at the concentrations used in the assays. Re-
placement of the amino-terminal Phe by Lys, in TA or its D-
form, reduced activity against staphylococci and enterococci
roughly 10-fold. Additionally, the killing curves indicated that
the bacterial populations were very homogeneous and that
there was no heterogenic resistance against TA analogs
among these strains (data not shown).
3.3. Determination of peptide conformation by circular
dichroism and NMR
CD spectroscopy was used to determine the conformation
of TA in solution conditions. In H2O, TA gave spectra with a
minimum close to 200 nm and an overall shape suggesting a
random coil conformation, as shown for the wild type in Fig.
2. A gradual change from a random coil to an K-helical con-
formation was observed when increasing amounts of TFE
were added to the TA peptide in H2O. The maximal e¡ect
was obtained already with 30% TFE.
NMR spectroscopy was used to further assess the structure
of the TA peptide. In water, TA was largely in a random coil
conformation as indicated by the typical crowding of the NH
resonances due to fast exchange with water [11]. The chemical
shifts of the alpha protons (chemical shift index, CSI) are
sensitive for the secondary elements in proteins [12]. Accord-
ing to CSI, the TA peptide adopts K-helical structure in
Table 2
MICa values for TA and analogs
Bacterial strain Peptide
TA DTA K1TA DK1TA K7TA A512TA L512TA
S. aureus
K52b 5.2 3.1 58.2 49.5 4.4 s 99.8 2.8
K35c 2.6 3.1 58.2 49.5 4.4 s 99.8 2.8
ATCC 25923 2.6 2.6 83.7 41.9 5.2 s 167.5 5.2
E. faecalis
ATCC 29212 20.9 10.5 s 167.5 167.5 20.9 s 167.5 10.5
E. faecium
18578d 10.5 12.5 s 116.3 99.0 17.5 s 99.8 5.6
18172d 10.5 12.5 s 116.3 49.5 17.5 s 99.8 5.6
aMinimal inhibitory concentration (WM).
bMethicillin-sensitive.
cMethicillin-resistant.
dVancomycin-resistant.
Fig. 2. CD spectra of TA in H2O and TFE. In water, TA has a
random coil structure, but adopts a mainly K-helical structure in
TFE, the maximal e¡ect is obtained already in 30% TFE solution.
Fig. 3. Molecular models of TA (top), L512TA (middle), and
A512TA (bottom), showing the carbon skeletons of each peptide in
the same orientation, and the van der Waals surfaces of Ile, Leu
and Ala. The N- and C-termini of the peptide are located on the
left and right sides of the ¢gure, respectively. Each peptide was
modeled as a complete K-helix using the Swiss PDB Viewer pro-
gram [10].
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TFE/water (3:7, v/v) solutions (data not shown). These ¢nd-
ings agree well with the CD data (see above).
4. Discussion
In the present study we demonstrated that it is possible to
improve the antibiotic activity of TA. By modifying a single
amino acid residue (IleCLeu) at two positions (5 and 12) in
the peptide a 1.9-fold enhancement in antibacterial activity
was obtained with E. faecium strains, and with one of S.
aureus strains. Additional studies will be necessary to deter-
mine if the improvement in activity requires replacements at
both positions, or if replacement at only one position is su⁄-
cient. Replacement of Leu with Ile or Ala showed that a
bulky, hydrophobic side chain is required at positions 5
and(/or) 12 (see Fig. 3). There are small, but apparently sig-
ni¢cant, di¡erences between the physical properties of the side
chains of Ile and Leu, and larger ones between Ile and Ala.
The solvent accessible surface areas of Ile, Leu, and Ala side
chains are 175, 170, and 115 Aî 2, respectively [13], and the
relative hydrophobicities are 2.5, 1.8 and 0.5 kcal/mol, respec-
tively, relative to a value of 0 kcal/mol for Gly [14]. The
results obtained for the Ile to Ala replacement can be com-
pared to those obtained in experiments with a two-stranded,
70-residue (2U35), K-helical, coiled-coil peptide in which it
was shown that the replacement of eight Leu residues, by
Ala, destabilized the coiled-coil conformation [15]. The dimer
was stabilized by hydrophobic interactions between nine Leu
residues in each of its two chains, and their partial replace-
ment reduced the ability of the two chains to pack into an
optimal coiled-coil conformation. By analogy, the Ile to Ala
replacements in TA may reduce the optimal packing of pep-
tides in an aggregate structure, such as an ion channel. It is
also interesting to consider that the side chain of Ile has a
chiral center, so that there would be four di¡erent isomers of
TA, and these isomers may not have equivalent activities.
The TFE solutions mimic quite well hydrophobic condi-
tions. It is known, however, that TFE may introduce K-helical
structures in proteins. According to the results of CD and
NMR spectroscopy, TA is mainly random coil in water solu-
tions, showing no aggregation behavior. However, even in
relatively small TFE concentrations, TA adopts a mainly K-
helical structure, which is in agreement with the postulated
membrane interaction.
Conversion of the N-terminal Phe of TA to Lys resulted in
drastic reduction of antibacterial activity both against S. aur-
eus and enterococcal test strains as measured by MIC and
killing activity determinations. Most studies of antibiotic pep-
tides from animal sources indicate that amphipathicity of the
peptide is important for antibacterial activities [16]. Fig. 1
illustrates the orientation of amino acids in TA when it is in
a helical conformation, and it is obvious that the substitution
of Lys for Phe at position 1 of TA, when it is converted to
K1TA will disrupt the amphipathic character of the peptide,
as this substitution will place a charged, hydrophilic amino
acid side chain on a side of the helix in which the surface is
completely hydrophobic.
In regard to the ion channel hypothesis for the mechanism
of action of antibiotic peptides, temporins have all of the
features required to satisfy this model except that they are
not long enough to span a bilayer membrane as K-helices, a
property requiring a length of 20 amino acids for a 30 Aî thick
membrane [17]. However, it would be possible for the tempo-
rins to span a bilayer if two molecules were oriented end-to-
end, as has been suggested for ion channels composed of the
15-residue peptide antibiotic, gramicidin [18].
This is the ¢rst report of the synthesis of TF (or K7TA),
which had a slightly reduced antibacterial activity relative to
TA against test organisms. TF and TA are equally hydropho-
bic by RP-HPLC [1], so the slight reduction in activity accom-
panying the Arg to Lys replacement may be due to the di¡er-
ence in pK values of the side chains of Arg (V12.5) and Lys
(V10.8) resulting in about a 50-fold reduction in the amount
of cationic peptide in solution.
The fact that enantiomeric TA (DTA) was as active as
native TA indicates that the mechanism of action of TA on
bacteria is not chiral, such as a receptor^ligand interaction. It
may be a simple hydrophobic interaction with membrane lip-
ids [19]. Also, since DTA would be less susceptible to proteol-
ysis than TA, it could be a useful replacement for TA in
situations where proteolysis is a problem. Based on the results
obtained for L512TA and both all-D enantiomers (DTA and
DK1TA), it would be reasonable to anticipate that an all-D
enantiomer of L512TA would also be at least as active as the
all-L isomer, and, in addition, it would be less expensive to
produce due to the di¡erence in the cost of D-Ile versus D-
Leu.
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